These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 21474360

  • 1. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
    Bruttomesso D, Bonomo M, Costa S, Dal Pos M, Di Cianni G, Pellicano F, Vitacolonna E, Dodesini AR, Tonutti L, Lapolla A, Di Benedetto A, Torlone E, Italian Group for Continuous Subcutaneous Insulin Infusion in Pregnancy.
    Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
    [Abstract] [Full Text] [Related]

  • 2. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I, Ortego J, Valencia I, García-Palacios MV, Aguilar-Diosdado M.
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [Abstract] [Full Text] [Related]

  • 3. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
    Talaviya PA, Saboo BD, Joshi SR, Padhiyar JN, Chandarana HK, Shah SJ, Vyas CK, Shah AN.
    Diabetes Metab Syndr; 2013 Sep; 7(2):68-71. PubMed ID: 23680243
    [Abstract] [Full Text] [Related]

  • 4. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
    Giménez M, Conget I, Nicolau J, Pericot A, Levy I.
    Acta Diabetol; 2007 Mar; 44(1):34-7. PubMed ID: 17357884
    [Abstract] [Full Text] [Related]

  • 5. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
    González-Romero S, González-Molero I, Fernández-Abellán M, Domínguez-López ME, Ruiz-de-Adana S, Olveira G, Soriguer F.
    Diabetes Technol Ther; 2010 Apr; 12(4):263-9. PubMed ID: 20210564
    [Abstract] [Full Text] [Related]

  • 6. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A.
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [Abstract] [Full Text] [Related]

  • 7. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
    EQuality1 Study Group--Evaluation of QUALITY of Life and Costs in Diabetes Type 1, Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, Capani F, Bruttomesso D, Di Bartolo P, Girelli A, Leonetti F, Morviducci L, Ponzi P, Vitacolonna E.
    Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
    [Abstract] [Full Text] [Related]

  • 8. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW.
    Clin Ther; 2007 Feb; 29 Suppl D():S135-44. PubMed ID: 18191065
    [Abstract] [Full Text] [Related]

  • 9. Association between preconceptional treatment with insulin pumps and improved metabolic status in early pregnancy in women with type 1 diabetes.
    Gutaj P, Zawiejska A, Brązert J, Wender-Ożegowska E.
    Pol Arch Med Wewn; 2015 Feb; 125(5):329-36. PubMed ID: 25827639
    [Abstract] [Full Text] [Related]

  • 10. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy.
    Lapolla A, Dalfrà MG, Masin M, Bruttomesso D, Piva I, Crepaldi C, Tortul C, Dalla Barba B, Fedele D.
    Acta Diabetol; 2003 Sep; 40(3):143-9. PubMed ID: 14605971
    [Abstract] [Full Text] [Related]

  • 11. Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women.
    Mello G, Biagioni S, Ottanelli S, Nardini C, Tredici Z, Serena C, Marchi L, Mecacci F.
    J Matern Fetal Neonatal Med; 2015 Feb; 28(3):276-80. PubMed ID: 24724804
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC, Sutton AJ.
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [Abstract] [Full Text] [Related]

  • 16. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D, Rizzi A, Scavone G, Tanese L, Zaccardi F, Manto A, Ghirlanda G.
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [Abstract] [Full Text] [Related]

  • 17. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
    Sahin SB, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C.
    Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
    [Abstract] [Full Text] [Related]

  • 18. Use of insulin glargine during pregnancy.
    Pöyhönen-Alho M, Rönnemaa T, Saltevo J, Ekblad U, Kaaja RJ.
    Acta Obstet Gynecol Scand; 2007 Oct; 86(10):1171-4. PubMed ID: 17851816
    [Abstract] [Full Text] [Related]

  • 19. Use of insulin glargine during pregnancy: a case-control pilot study.
    Price N, Bartlett C, Gillmer M.
    BJOG; 2007 Apr; 114(4):453-7. PubMed ID: 17261126
    [Abstract] [Full Text] [Related]

  • 20. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
    Abell SK, Suen M, Pease A, Boyle JA, Soldatos G, Regan J, Wallace EM, Teede HJ.
    Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.